4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-24-000113
CIK 0000875320other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:02 PM ET
Size
6.1 KB
Accession
0000875320-24-000113
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-04-01$418.10/sh−225$94,073→ 7,740 total - Sale
Common Stock
2024-04-02$419.00/sh−240$100,560→ 7,500 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:02 PM ET
- Size
- 6.1 KB